The bleeding-edge of weight-loss medication. Known as a "triple-G" agonist, it targets GLP-1, GIP, and Glucagon receptors simultaneously. Currently in late-stage clinical trials, it is showing unprecedented weight loss results that rival bariatric surgery.
What is this used for?
What dose is typical for your goal?
- Typical dose
- 1–12 mg
- How it's taken
- Injection under the skin
- How often
- Once a week
- Most common starting point
- 1 mg weekly, gradually increasing over months
Based on published studies and what providers typically prescribe.
These are typical doses from research and real prescriptions — not a recommendation for you specifically. Your provider will adjust based on your body, your goals, and your health history.
Want your exact dose? A provider will personalize this for you.
Find a ProviderHow do you take it?
These are typical doses from research and real prescriptions — not a recommendation for you specifically. Your provider will adjust based on your body, your goals, and your health history.
Can this be combined with other peptides?
How well researched is this?
Strong Animal & Lab Research
Currently in Phase 3 clinical trials (estimated completion 2025/2026). Published Phase 2 data in the New England Journal of Medicine is historically unprecedented.
Legal status
Currently restricted by the FDA and cannot be legally compounded. This status may change — we'll update this page when it does.
2026 reclassification status updates coming soon.
Purity
Purity measures how clean and accurate the compound is. Higher purity means fewer contaminants and more reliable dosing.
HPLC Purity Tested
Always require a Certificate of Analysis (CoA) from a US-based compounding pharmacy.
Common questions
Ready to start?
Consult with a licensed provider to determine the right protocol for your goals.



